Faculty Opportunities. SHARE. St. Louis, MO 63110-1093. Division of Student Affairs. A small clinical trial conducted by Rizwan Romee and Todd Fehniger provides evidence that the immune systems "natural killer" cells can be dialed up in the laboratory, trained to recall that activation and then effectively unleashed to destroy cancer cells in some patients. By studying this group of patients, the investigators hope to understand the differences between those patients who go on to develop MDS and those who dont. With the new technique, mice underwent successful stem cell transplants from unrelated mice without evidence of dangerously low blood cell counts that are a hallmark of the traditional procedure. For patient appointments, call 314-362-8200. Experience the research, scholarship and creativity that drive us every day. FAQ, SAS Documentation They also are leaders inusing minimally invasive surgical techniques, which greatly reduce the need for large incisions and blood loss during surgery; these procedures include the use of laparoscopy, percutaneous renal (kidney) surgery, cystoscopic and ureteroscopic surgery, and lithotripsy for treating a wide range of tumors and other conditions. Length of Program Program Details Educational Goals Case Requirements Eligibility Requirements Licensure Requirements Application Process Contact Us Varun Puri, MD, MSCI 314-362-4191 Professor of Surgery The online resource, called CIViC, for Clinical Interpretations of Variants in Cancer, is open to anyone who wants to contribute or make use of the information. A phase 1 clinical trial atSiteman Cancer Center is underway to investigate a long-acting form of IL-7 in conjunction with CAR-T cells in patients with diffuse large B cell lymphoma. We are committed to learning and exploration, to discovery and impact. Which division will offer me the best chance of admission? Located in St. Louis, Missouri, Washington University School of Medicine lies in the heart of the Midwest. The study lays the foundation for finding new ways to treat prostate cancer, particularly for the most aggressive forms of the disease. His research over the past 25 years has focused on characterizing mechanisms regulating normal and malignant hematopoiesis. Facebook Courtesy photo. 314-454-6300. academicpediatrics@wustl.edu Email. The division utilizes 27,039 square feet for its research, clinical, and education mission. How much does Washington University in St. Louis in the United States pay? All first-year students come into WashU . The strategy, developed in mouse studies, lets chemotherapy penetrate the protective environment of bone and minimizes toxic side effects. WU Record 1/20/21 | Gastroenterology 2021 Jan 20, Jeff Ward and Chris Miller are members of a global consortium that has identified features of tumor neoantigens that trigger T cells to attack the cancer and leave healthy tissue untouched. Both studies appear in the August 31 issue of PLOS Medicine, which is a special issue of the journal dedicated to liquid biopsies. WU Record 4/30/19, Washington University School of Medicine has received a $9 million grant from the National Institutes of Health to study the life histories of breast and pancreatic cancers. Twitter; RESOURCES. Campus Box 8226, St. Louis, MO 63110-1093 (800) 852-9074. dbbs-info@wustl.edu. To provide the highest quality of patient care, surgical education, innovative research and community outreach, the Department of Surgery is organized into 6 divisions. UNIVERSITY COVID-19 INFORMATION WU Record 1/26/21 | Cell Reports 2021 Jan 26, Research published by Ramon Jin, a clinical fellow in the Division of Medical Oncology, and co-workers in Jason Mills's laboratory suggests that people with Barretts esophagus (a major risk factor for cancer of the esophagus) may be vulnerable to infection after swallowing the virus that causes COVID-19. Molecular Genetics and Genomics. . The drug is designed to shut down the effects of the mutation, which is found in about 13% of patients with lung adenocarcinoma, a common type of non-small-cell lung cancer. Genome sequencing and protein analysis of the tumors will be performed to seek clues to how some of them develop drug resistance. These results form the basis of a planned clinical trial in patients with sarcomas. The findings may enable development of more effective therapies tailored to patients, based on the genetic characteristics of their cancer cells. Here are a few highlights: 1983: In vitro fertilization (IVF) program - the first in St. Louis - begins in partnership with Jewish Hospital. WU Record 9/11/19, A team of Washington University investigators led by Tim Ley have been awarded a $15 million NIH grant to better understand the genetic changes that drive acute myeloid leukemia and predict patients responses to therapy. Four years ago, Lynn was diagnosed with dementia but decided against having a spinal tap that would have shown whether the cause was Alzheimer's disease. Molecular Cell Biology. They used computer modeling to accurately predict 75% of effective neoantigens and eliminate 98% of ineffective mutant proteins in melanoma and a common type of lung cancer. Employee Self Service Now, Wang-Sik Lee and Stuart Kornfeld, in collaboration with Huilin Li at the Van Andel Institute, show how this enzyme discriminates between the lysosomal hydrolases and numerous other secreted glycoproteins having identical glycan chains, thereby ensuring that only the former acquire the Man-6-P tag. Facebook; Twitter November 17, 2022 ST. LOUIS Joe knew something was terribly wrong when his wife, an energetic nurse and mother of three, became forgetful in her early 60s. People | Division of Urologic Surgery | Washington University in St. Louis People Urologists in the Division of Urologic Surgery are part of the Washington University Physicians medical group, which is recognized as an international leader in providing innovative, high-quality medical care. But when combined with immunotherapy, the compound significantly shrank tumors and dramatically improved survival in the animals. Down-regulation of PCAT-14 is associated with a greater probability of metastatic progression, and this finding may help to determine the intensity of therapy in individual patients. Learn more about the division Division Leadership & Faculty The Public Health Sciences division is led by Graham Colditz, MD, DrPH, an internationally recognized leader in cancer prevention. WU Record 12/1/21 | Sci Transl Med 2021 Dec, Elaine M. Majerus, MD, PhD and Stephen T. Oh, MD, PhD, have been named co-Chiefs of the Division of Hematology in the Department of Medicine, effective December1, 2021. A new study conducted by Jian Campian, Milan Chheda and colleagues shows that treatment with the immune-boosting protein interleukin 7 (IL-7) in combination with radiation improves survival in mice with glioblastoma. Walter, an international leader in the study and treatment of myelodysplastic syndromes (MDS), a group of rare blood disorders that prevents the body from making sufficient healthy blood cells, is a professor of medicine and director of the Edward P. Evans Center for Myelodysplastic Syndromes at the School of Medicine. 314-935-4526. WU Record 7/29/16, David DeNardo, Andrea Wang-Gillam and their colleagues have shown that immunotherapy against pancreatic cancer can be effective when given in conjunction with focal adhesion kinase (FAK) inhibitors, drugs that break up the fibrous tissue in these tumors. December 1, 2022. He is being recognized for leading the effort to sequence the first human cancer genomes, from patients with acute myeloid leukemia (AML). St. Louis Children's Hospital is a Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies. St. Louis, MO Washington University (Missouri) Conference . To schedule a virtual visit please call 314-362-8200 or request an appointment online . We want to apply our findings in ways that wont cause more disparities, wont cause stigmatization., America has long had the highest rates of poverty among the wealthy industrialized countries Rather than providing support to the poor, U.S. social policies appear designed to punish and stigmatize them., Herbert S. Hadley Professor of Social Welfare, Computing challenges today are data-intensive. studentaffairs@wustl.edu. Living in St Louis. We are a community where you can be an individual and achieve exceptional things. 12/Missouri Valley . Its academic mission centers around biostatistical excellence in clinical, epidemiological and genetic studies. The results will help researchers design better immunotherapies against cancer. Many of our skin doctors participate in clinical research giving patients access to new drug therapies and treatments. Office Location: 1 Barnes-Jewish Hospital Plaza. WU Record 6/4/21 | NEJM 2021 Jun 4, Stuart Kornfeld is one of six people who received honorary degrees at Washington University's commencement on May 20-21. St. Louis, MO 63110-1093. Newly approved by the Food and Drug Administration (FDA) for types of advanced non-Hodgkin lymphoma in adults, the CAR-T cell therapy harnesses a patients own immune system to fight cancer. WU Record 3/7/22 | Gastroenterology 2022 Mar 7, Glioblastoma, an aggressive cancer in the brain or spinal cord, has proven stubbornly resistant to radiation, chemotherapy, and newer immunotherapies, with fewer than 10% of patients surviving longer than five years after diagnosis. WU Record 5/31/22 | Clin Cancer Res 2022 Apr 14, Cells synthesize 60 to 70 lysosomal hydrolases that must be delivered to the lysosome to allow proper functioning of this organelle. . WU Record 5/5/21, The Zika virus that ravaged the Americas, leaving many babies with permanent brain damage, may have a silver lining, according to a study published by Milan Chheda and colleagues. We look for the same qualities in our applicants across all academic divisions at WashU, and we encourage you to apply to the school that offers courses and majors in which you are most interested at the time . WU Record 10/18/21 | J Clin Oncol 2021 Oct 18, About 78-92% of lung cancers in patients who have never smoked can be treated with precision drugs already approved by the Food and Drug Administration to target specific mutations in a patients tumor. WU Record 8/31/21 | Article 1 | Article 2, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is planning a new, nine-story facility on the Washington University Medical Campus dedicated solely to outpatient cancer care. I look forward to engaging with you. WU Record 5/18/16, Ramaswamy Govindan has been named the Anheuser-Busch Endowed Chair in Medical Oncology. Washington University in St. Louis (WashU, or WUSTL) is a private research university with its main campus in St. Louis County, and Clayton, . ASH press release 6/6/22 | Wash U HFFTP website. WU Record 7/3/19 | Science Translational Medicine 2019 Jul 3, Tim Ley led the team that first sequenced a cancer genome, identifying mutations in DNA that lead to cancer growth. Timothy J. Ley, MD, the Lewis T. and Rosalind B. Apple Professor of Medicine, has been honored by the American Society of Hematology with the Henry Stratton Medal, awarded annually to one basic scientist and one clinical or translational researcher who have made outstanding contributions to hematology. Washington University in St. Louis Men's Soccer Program Information Powered by One Brookings Drive Saint Louis, MO 63130 (314) 935-5000 http://www.wustl.edu Year Founded: 1853 Religious Affiliation: None College Type: Private , Suburban Enrollment: 7653 (full time undergrad) Tuition In State: $57,750 Tuition Out of State: $57,750 Division: These leading-edge treatments have contributed to the divisions consistent ranking by U.S. News & World Report among the top urologic surgery centers in the United States. Department of Medicine Announcement. POSTED. Altogether, they identified about 300 genes that drive tumor growth. Alone, the compound reduces pancreatic tumor growth and metastases. WU Record 1/9/19, Their gift establishes the Paula C. and Rodger O. Riney Blood Cancer Research Initiative Fund to develop promising new treatments for multiple myeloma. St. Louis, MO 63110. Contact Department of Pediatrics. The urologists in the Washington University Division of Urology are national leaders in the field of urology. Phone: 314-362-8940 | Fax: 314-362-2505. Website Read the Department of Surgery 2021 Annual Report to see our mission in action. Location & Hours. Divisions To better serve our mission of excellence in patient care, research and education, the department is divided into specialty divisions that focus on specific areas of internal medicine. INSTITUTE FOR INFORMATICS (I2) COVID-19 INFORMATION, Biostat Staff Page WU Record 8/21/19, More than 50 years ago, Stuart Kornfeld, was awarded his first research grant. The Washington University Dermatopathology Center is committed to providing expert interpretation of both routine and complex skin, hair and nail biopsy specimens. WU Record 6/13/22 | Nat Commun 2022 Jun 13, Synovial sarcoma is rare, with 900 to 1,000 new cases diagnosed annually, and is most typically diagnosed during adolescence and into young and middle adulthood. 660 South Euclid Avenue. You will be asked to select an academic division on your application for admission to WashU. Mailing Address. The division is well-known for its comprehensive program focused on the prevention, early detection and treatment of early- and advanced-stage prostate cancers. Li Ding, assistant director of The McDonnell Genome Institute at Washington University, and scientists from about 20 other institutions have completed the genetic analyses of more than 11,000 tumors from patients, spanning 33 types of cancer - all part of The Cancer Genome Atlas (TCGA) project. Racial and Socioeconomic Differences in Acral Lentiginous Melanoma Outcomes: A Surveillance, Epidemiology, and End Results Analysis, J Am Acad Dermatol 2022 Oct;87(4):866-867, First-In-Human Phase 1/1b Study to Evaluate Sitravatinib in Patients With Advanced Solid Tumors, TGF-Beta Signaling in Myeloproliferative Neoplasms Contributes to Myelofibrosis Without Disrupting the Hematopoietic Niche, J Clin Invest 2022 Apr 19:e154092; [ahead of print], Structure of the Human GlcNAc-1-Phosphotransferase Subunits Reveals Regulatory Mechanism for Lysosomal Enzyme Glycan Phosphorylation, Nat Struct Mol Biol 2022 Mar 24; [ahead of print], Antibody-Drug Conjugates Plus Janus Kinase Inhibitors Enable MHC-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation, J Clin Invest 2021 Nov 2; [Epub ahead of print], U2af1 Is a Haplo-Essential Gene Required for Hematopoietic Cancer Cell Survival in Mice, J Clin Invest 2021 Sep 21; [Epub ahead of print], Breast Cancer Derived GM-CSF Regulates Arginase 1 in Myeloid Cells to Promote an Immunosuppressive Microenvironment, J Clin Invest 2021 Sep 14; [Epub ahead of print], KTE-X19 for Relapsed or Refractory Adult B-Cell Acute Lymphoblastic Leukaemia: Phase 2 Results of the Single-Arm, Open-Label, Multicentre ZUMA-3 Study, Sotorasib for Lung Cancers With KRAS P.G12C Mutation, N Engl J Med 2021 Jun 4; [Epub ahead of print], Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers, Proteogenomic and Metabolomic Characterization of Human Glioblastoma, Cancer Cell 2021 Feb 2;S1535-6108(21)00050-7, Metabolic Compensation Activates Pro-Survival mTORC1 Signaling Upon 3-Phosphoglycerate Dehydrogenase Inhibition in Osteosarcoma, TPL2 Enforces RAS-Induced Inflammatory Signaling and Is Activated by Point Mutations, J Clin Invest 2020 Jun 23; [Epub ahead of print], Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer, Potently Cytotoxic Natural Killer Cells Initially Emerge From Erythro-Myeloid Progenitors During Mammalian Development, Exploring the "Minimal" Structure of a Functional ADAMTS13 by Mutagenesis and Small-Angle X-Ray Scattering, Posttranscriptional Modulation of TERC by PAPD5 Inhibition Rescues Hematopoietic Development in Dyskeratosis Congenita, Mutation Clearance After Transplantation for Myelodysplastic Syndrome, N Engl J Med 2018 Sep 13;379(11):1028-1041, An "Off-The-Shelf" Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies. Based on the results of the survey, the investigators are launching a pilot study in which facilitators will be matched with patients of the same race to perform in-person genetic screens. . Benefits eligibility is subject to employment status, full-time equivalent (FTE) workload, and weekly standard hours. Cell 2018 Jul 19 | WU Record 7/19/18, Ron Bose and Cynthia Ma have received a $5 million grant from the Department of Defense to support their research on HER2-positive breast cancer. 1 Brookings Drive. John T. Milliken Department of Medicine. Tweets by WashUNeurology COVID-19 Resources; Canvas; Harnessing new technologies, including proteomics, metabolomics and single cell sequencing, this study is an extremely deep dive into glioblastoma tumor biology, revealing new possibilities for therapy. LEARN ABOUT THE DIVISION. The Washington University Senescence Tissue Mapping Center, led by principal investigator Li Ding will map out senescent cells in bone marrow and liver samples in an effort to understand their spatial distribution and molecular signature in different tissue environments and at different ages. . Computational and Systems Biology. St. Louis, MO. After analyzing the complex metabolism of these tumors, Brian Van Tine, Jason Held, and co-workers discovered that adding a glutamine inhibitor to an arginine-depleting drug killed the cells and caused tumor regression inmice. A new study in mice led by Miriam Kim and John DiPersio shows that additional treatment with an immunity-boosting protein called interleukin 7 (IL-7) causes the cancer-fighting CAR-T cells to grow in number and become more effective at killing tumor cells. We want you to engage with your peers and with your university, to create an experience where you can learn and grow. 660 S. Euclid Ave. MSC 8208-16-01. WU Record 10/9/20 | Cell 2020 Oct 2, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis has been recognized once again as a top U.S. cancer institution, based on a review of its research programs. Studying mice, they found that the drug also may reduce some of the damaging side effects of the chemotherapy cocktail FOLFIRINOX (a combination of folinic acid, 5-fluorouracil, irinotecan and oxaliplatin), commonly used to treat pancreatic cancer. Division surgeons are leaders in offering function-preserving surgical techniques that preserve erection among men with prostate cancer, ejaculation among men with testes cancer, and bladder function among all patients with bladder cancer. Contact Us . New research from the labs of Milan Chheda and Michael Diamond at Washington University and Jeremy Rich at UC San Diego shows that the virus kills brain cancer stem cells, the kind of cells most resistant to standard treatments. In a study led by Li Ding, members of the National Cancer Institutes Clinical Proteomic Tumor Analysis Consortium performed high-resolution and high-depth analyses on 99 glioblastoma tumors. For over 50 years, the division has been involved in the treatment, research and training of diseases of the digestive tract. WU Record 3/5/18, While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer. Washington University School of Medicine. The division develops and adopts innovative approaches to engineering education and support the school's departments and their educational initiatives. Washington University School of Medicine Facts . Division of Maternal-Fetal Medicine & Ultrasound | Obstetrics & Gynecology | Washington University in St. Louis Division of Maternal-Fetal Medicine & Ultrasound Chief: Anthony Odibo, MD, MSCE The Division of Maternal Fetal Medicine and Ultrasound provides comprehensive assessment, care and consultation to pregnant women and their physicians. WU Record 9/1/22 | JAMA Oncol 2022 Sep 1, A detailed analysis of pancreatic cancer has revealed details of two key transition points in the development of these tumors the shift from normal cells to precancerous cells, and the change from precancerous to cancerous cells. Phone: 314-935-4526. Overall admission percentages within our divisions may vary from year to year. Phone: 314-362-1700 | Fax: 314-362-9878. hospitalist@wustl.edu. Brian Van Tine and his colleagues have developed a way to attack this tumor using an investigational drug that triggers cell death. Division of Pediatric Critical Care Medicine. Washington University in St. Louis is a private institution that was founded in 1853. Washington University in St. Louis School of Medicine's Division of Biostatistics offers the Master of Science in Biostatistics (MSIBS) degree program. Please visit our website at https://hr.wustl.edu/benefits/ to view a summary of benefits. Vice Chancellor for Student Affairs. Dr. Paul comes to us from the George Washington University . View contacts About the division: Danforth University Center, Suite 200; studentaffairs@wustl.edu; 314-935-4526; Hours: Mon-Fri 8:30 a.m.-5 p.m. . These minimally invasive procedures also reduce patient hospital stays, at-home recovery times and missed work days. Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Dong J, Adhikary S, Zhou L, Schuberth PC, Faghmous I, Masouleh BK, Houot R J Hematol Oncol 2022 Dec 10;15(1):170, Montoya LM, Kosorok MR, Geng EH, Schwab J, Odeny TA, Petersen ML Biometrics 2022 Dec 9; [ahead of print], Meroni A, Grosser J, Agashe S, Ramakrishnan N, Jackson J, Verma P, Baranello L, Vindigni A Sci Adv 2022 Dec 9;8(49):eabq0648, Covut F, Sanfilippo KM Hematology Am Soc Hematol Educ Program 2022 Dec 9;2022(1):363-367, Tian R, Wiley B, Liu J, Zong X, Truong B, Zhao S, Uddin MM, Niroula A, Miller CA, Mukherjee S, Heiden BT, Luo J, Puri V, Kozower BD, Walter MJ, Ding L, Link DC, Amos CI, Ebert BL, Govindan R, Natarajan P, Bolton KL, Cao Y J Clin Oncol 2022 Dec 8:JCO2200857; [ahead of print], Kim S, Lim S, Kim B, Ritchey J, Vij K, Prior J, Marsala L, Stoner A, Gao F, Achilefu S, Cooper ML, DiPersio JF, Choi J Blood 2022 Dec 7:blood2021012687; [ahead of print], Barlin M, Erdmann-Gilmore P, Mudd JL, Zhang Q, Seymour RW, Guo Z, Miessner JR, Goedegebuure SP, Bi Y, Osorio OA, Alexander-Brett J, Li S, Ma CX, Fields RC, Townsend RR, Held JM Mol Cell Proteomics 2022 Dec 2:100476; [ahead of print], Tepper SC, Holten AK, Jeffe DB, England PH, Hong ZL, Perez M, Ghert M, Hirbe AC, Cipriano CA Surg Oncol 2022 Dec;45:101861, Al-Kadhimi Z, Callahan M, Fehniger T, Cole KE, Vose J, Hinrichs S Int Immunopharmacol 2022 Dec;113(Pt A):109387, Kitko CL, Arora M, DeFilipp Z, Zaid MA, Di Stasi A, Radojcic V, Betts CB, Coussens LM, Meyers ML, Qamoos H, Ordentlich P, Kumar V, Quaranto C, Schmitt A, Gu Y, Blazar BR, Wang TP, Salhotra A, Pusic I, Jagasia M, Lee SJ J Clin Oncol 2022 Dec 2:JCO2200958; [ahead of print], Berchuck JE, Facchinetti F, DiToro DF, Baiev I, Majeed U, Reyes S, Chen C, Zhang K, Sharman R, Uson Junior PLS, Maurer J, Shroff RT, Pritchard CC, Wu MJ, Catenacci DVT, Javle M, Friboulet L, Hollebecque A, Bardeesy N, Zhu AX, Lennerz JK, Tan B, Borad M, Parikh AR, Kiedrowski LA, Kelley RK, Mody K, Juric D, Goyal L Ann Oncol 2022 Dec;33(12):1269-1283, SanMiguel JM, Eudy E, Loberg MA, Young KA, Mistry JJ, Mujica KD, Schwartz LS, Stearns TM, Challen GA, Trowbridge JJ Cancer Discov 2022 Dec 2;12(12):2763-2773, Lander VE, Belle JI, Kingston NL, Herndon JM, Hogg GD, Liu X, Kang LI, Knolhoff BL, Bogner SJ, Baer JM, Zuo C, Borcherding NC, Lander DP, Mpoy C, Scott J, Zahner M, Rogers BE, Schwarz JK, Kim H, DeNardo DG Cancer Discov 2022 Dec 2;12(12):2774-2799, Slade M, Martin TG, Nathwani N, Fiala MA, Rettig MP, Gao F, Deol A, Buadi FK, Kaufman JL, Hofmeister CC, Gregory TK, Berdeja J, Chari A, Rosko A, Vij R Leukemia 2022 Dec;36(12):2917-2921, Goldsmith SR, Streeter S, Covut F Curr Hematol Malig Rep 2022 Dec;17(6):286-297, De Togni E, Wan F, Slade M, Plach K, Abboud R Leuk Lymphoma 2022 Dec;63(12):2975-2981, Lavasidis G, Markozannes G, Voorhies K, Trikalinos NA, Petridou ET, Panagiotou OA, Ntzani EE Crit Rev Oncol Hematol 2022 Dec;180:103845, McHenry S, Zong X, Shi M, Fritz CDL, Pedersen KS, Peterson LR, Lee JK, Fields RC, Davidson NO, Cao Y Hepatol Commun 2022 Dec;6(12):3299-3310, Dehdashti F, Reimers MA, Shoghi KI, Chen DL, Luo J, Rogers B, Pachynski RK, Sreekumar S, Weimholt C, Zhou D Mol Imaging Biol 2022 Dec;24(6):853-861, Patel DA, Kahl BS Cancer 2022 Dec 1;128(23):4047-4051, Wang TF, Sanfilippo KM, Douketis J, Falanga A, Karageorgiou J, Maraveyas A, Ortel TL, Soff G, Vedantham S, Zwicker JI J Thromb Haemost 2022 Dec;20(12):3026-3038, Ji JX, Cochrane DR, Negri GL, Colborne S, Spencer Miko SE, Hoang LN, Farnell D, Tessier-Cloutier B, Huvila J, Thompson E, Leung S, Chiu D, Chow C, Ta M, Kobel M, Feil L, Anglesio M, Goode EL, Bolton K, Morin GB, Huntsman DG J Pathol 2022 Dec;258(4):325-338, Trikalinos NA, Hammill C, Liu J, Navale P, Winter K, Chatterjee D, Iravani A, Amin M, Itani M Abdom Radiol (NY) 2022 Dec;47(12):4096-4102, Yano M, Shetty AS, Williams GA, Lancia S, Trikalinos NA, Hammill CW, Hawkins WG, Salter A, Chatterjee D Abdom Radiol (NY) 2022 Dec;47(12):3971-3985, Khaddour K, Zhou A, Butt OH, Budde G, Malashevich AK, Ansstas G Front Oncol 2022 Nov 17;12:978996, Heiden BT, Eaton DB, Chang SH, Yan Y, Schoen MW, Thomas TS, Patel MR, Kreisel D, Nava RG, Meyers BF, Kozower BD, Puri V J Natl Cancer Inst 2022 Nov 29:djac208; [ahead of print], Grierson PM, Tan B, Pedersen KS, Park H, Suresh R, Amin MA, Trikalinos NA, Knoerzer D, Kreider B, Reddy A, Liu J, Der CJ, Wang-Gillam A, Lim KH Oncologist 2022 Nov 25:oyac237; [ahead of print], Duncavage EJ, Bagg A, Hasserjian RP, DiNardo CD, Godley LA, Iacobucci I, Jaiswal S, Malcovati L, Vannucchi AM, Patel KP, Arber DA, Arcila ME, Bejar R, Berliner N, Borowitz MJ, Branford S, Brown AL, Cargo CA, Dohner H, Falini B, Garcia-Manero G, Haferlach T, Hellstrom-Lindberg E, Kim AS, Klco JM, Komrokji R, Lee-Cheun Loh M, Loghavi S, Mullighan CG, Ogawa S, Orazi A, Papaemmanuil E, Reiter A, Ross DM, Savona M, Shimamura A, Skoda RC, Sole F, Stone RM, Tefferi A, Walter MJ, Wu D, Ebert BL, Cazzola M Blood 2022 Nov 24;140(21):2228-2247, Berrien-Elliott MM, Jacobs MT, Fehniger TA Blood 2022 Nov 23:blood2022016200; [ahead of print], Ince S, Itani M, Henke LE, Smith RK, Wise PE, Mutch MG, Glasgow SC, Silviera ML, Pedersen KS, Hunt SR, Kim H, Fraum TJ Tomography 2022 Nov 9;8(6):2723-2734, Clifton K, Gao F, Jabbari J, Van Aman M, Dulle P, Hanson J, Wildes TM J Geriatr Oncol 2022 Nov;13(8):1122-1131, Noel MS, Kim S, Hartley ML, Wong S, Picozzi VJ, Staszewski H, Kim DW, Van Tornout JM, Philip PA, Chung V, Ocean AJ, Wang-Gillam A Cancer Med 2022 Nov;11(22):4169-4181, Bowman-Kirigin JA, Desai R, Saunders BT, Wang AZ, Schaettler MO, Liu CJ, Livingstone AJ, Kobayashi DK, Durai V, Kretzer NM, Zipfel GJ, Leuthardt EC, Osbun JW, Chicoine MR, Kim AH, Murphy KM, Johanns TM, Zinselmeyer BH, Dunn GP Cancer Immunol Res 2022 Nov 21:CIR-22-0098; [ahead of print], Berrian J, Liu Y, Ezenwajiaku N, Moreno-Aspitia A, Holton SJ, Toriola AT, Colditz GA, Housten AJ, Hall L, Fiala MA, Ademuyiwa FO Cancer Med 2022 Nov 20; [ahead of print], Bardia A, Mayer I, Winer E, Linden HM, Ma CX, Parker BA, Bellet M, Arteaga CL, Cheeti S, Gates M, Chang CW, Fredrickson J, Spoerke JM, Moore HM, Giltnane J, Friedman LS, Chow Maneval E, Chan I, Jhaveri K Breast Cancer Res Treat 2022 Nov 19; [ahead of print], Rosenbaum E, Chugh R, Ryan CW, Agulnik M, Milhem MM, George S, Jones RL, Chmielowski B, Van Tine BA, Tawbi H, Elias AD, Read WL, Budd GT, Qin LX, Rodler ET, Hirman J, Weiden P, Bennett CM, Livingston PO, Ragupathi G, Hansen D, D'Angelo SP, Tap WD, Schwartz GK, Maki RG, Carvajal RD Eur J Cancer 2022 Nov;176:155-163, Butt OH, Zhou AY, Caimi PF, Luckett PH, Wisch JK, Derenoncourt P, Lee K, Wu GF, de Lima MJG, Campian JL, Frank MJ, DiPersio JF, Ghobadi A, Ances BM JAMA Oncol 2022 Nov 1;8(11):1652-1657, Ghobadi A, Slade M, Kantarjian H, Alvarenga J, Aldoss I, Mohammed KA, Jabbour E, Faramand R, Shah B, Locke F, Fingrut W, Park JH, Short NJ, Gao F, Uy GL, Westervelt P, DiPersio JF, Champlin RE, Al Malki MM, Ravandi F, Kebriaei P Blood 2022 Nov 17;140(20):2101-2112, Pemmaraju N, Kantarjian HM, Sweet KL, Wang ES, Senapati J, Wilson NR, Konopleva MY, Frankel AE, Gupta V, Mesa RA, Ulrickson ML, Gorak E, Bhatia S, Budak-Alpdogan T, Mason JR, Garcia-Romero MT, Lopez-Santiago NC, Cesarman-Maus G, Vachhani P, Lee S, Bhatt VR, Blum W, Walter RB, Bixby D, Gojo I, Duvic M, Rampal RK, de Lima M, Foran JM, Fathi AT, Hall A, Jacoby MA, Lancet JE, Mannis GN, Stein AS, Mims AS, Rizzieri D, Olin RL, Perl AE, Schiller GJ, Shami PJ, Stone RM, Strickland S, Wieduwilt MJ, Daver NG, Ravandi F, Vasu S, Guzman ML, Roboz GJ, Khoury JD, Qazilbash MH, Aung P, Cuglievan B, Madanat YF, Kharfan-Dabaja MA, Pawlowska AB, Taylor J, Tallman MS, Dhakal P, Lane AA Blood 2022 Nov 18:blood2022017865; [ahead of print], Kuruvilla J, Armand P, Hamadani M, Kline J, Moskowitz CH, Avigan D, Brody JD, Ribrag V, Herrera AF, Morschhauser F, Kanate A, Zinzani PL, Bitran J, Ghesquieres H, Schuster SJ, Farooqui M, Marinello P, Bartlett NL Leuk Lymphoma 2022 Nov 18:1-10; [ahead of print], Donahue K, Xie H, Li M, Gao A, Ma M, Wang Y, Tipton R, Semanik N, Primeau T, Li S, Li L, Tang W, Xu W J Biol Chem 2022 Nov 14:102700; [ahead of print], Liau LM, Ashkan K, Brem S, Campian JL, Trusheim JE, Iwamoto FM, Tran DD, Ansstas G, Cobbs CS, Heth JA, Salacz ME, D'Andre S, Aiken RD, Moshel YA, Nam JY, Pillainayagam CP, Wagner SA, Walter KA, Chaudary R, Goldlust SA, Lee IY, Bota DA, Elinzano H, Grewal J, Lillehei K, Mikkelsen T, Walbert T, Abram S, Brenner AJ, Ewend MG, Khagi S, Lovick DS, Portnow J, Kim L, Loudon WG, Martinez NL, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Giglio P, Gligich O, Krex D, Lindhorst SM, Lutzky J, Meisel HJ, Nadji-Ohl M, Sanchin L, Sloan A, Taylor LP, Wu JK, Dunbar EM, Etame AB, Kesari S, Mathieu D, Piccioni DE, Baskin DS, Lacroix M, May SA, New PZ, Pluard TJ, Toms SA, Tse V, Peak S, Villano JL, Battiste JD, Mulholland PJ, Pearlman ML, Petrecca K, Schulder M, Prins RM, Boynton AL, Bosch ML JAMA Oncol 2022 Nov 17; [ahead of print], Salvador C, Mark P, Hoenemeyer T, McDonald V Complement Ther Clin Pract 2022 Nov;49:101639, Chen H, Gesumaria L, Park YK, Oliver TG, Singer DS, Ge K, Schrump DS Mol Cancer Res 2022 Nov 15:MCR-22-0594; [ahead of print], Sridaran D, Chouhan S, Mahajan K, Renganathan A, Weimholt C, Bhagwat S, Reimers M, Kim EH, Thakur MK, Saeed MA, Pachynski RK, Seeliger MA, Todd Miller W, Feng FY, Mahajan NP Nat Commun 2022 Nov 14;13(1):6929, Krysiak K, Danos AM, Saliba J, McMichael JF, Coffman AC, Kiwala S, Barnell EK, Sheta L, Grisdale CJ, Kujan L, Pema S, Lever J, Ridd S, Spies NC, Andric V, Chiorean A, Rieke DT, Clark KA, Reisle C, Venigalla AC, Evans M, Jani P, Takahashi H, Suda A, Horak P, Ritter DI, Zhou X, Ainscough BJ, Delong S, Kesserwan C, Lamping M, Shen H, Marr AR, Hoang MH, Singhal K, Khanfar M, Li BV, Lin WH, Terraf P, Corson LB, Salama Y, Campbell KM, Farncombe KM, Ji J, Zhao X, Xu X, Kanagal-Shamanna R, King I, Cotto KC, Skidmore ZL, Walker JR, Zhang J, Milosavljevic A, Patel RY, Giles RH, Kim RH, Schriml LM, Mardis ER, Jones SJM, Raca G, Rao S, Madhavan S, Wagner AH, Griffith M, Griffith OL Nucleic Acids Res 2022 Nov 14:gkac979; [ahead of print], Bolton KL, Chen D, Corona de la Fuente R, Fu Z, Murali R, Kobel M, Tazi Y, Cunningham JM, Chan ICC, Wiley BJ, Moukarzel LA, Winham SJ, Armasu SM, Lester J, Elishaev E, Laslavic A, Kennedy CJ, Piskorz A, Sekowska M, Brand AH, Chiew YE, Pharoah P, Elias KM, Drapkin R, Churchman M, Gourley C, DeFazio A, Karlan B, Brenton JD, Weigelt B, Anglesio MS, Huntsman D, Gayther S, Konner J, Modugno F, Lawrenson K, Goode EL, Papaemmanuil E Clin Cancer Res 2022 Nov 14;28(22):4947-4956, Zimmerman SM, Nixon SJ, Chen PY, Raj L, Smith SR, Paolini RL, Lin PN, Souroullas GP Oncogene 2022 Nov;41(46):4983-4993, Lee S, Ma C, Shi Q, Kumar P, Couture F, Kuebler P, Krishnamurthi S, Lewis D, Tan B, Goldberg RM, Venook A, Blanke C, O'Reilly EM, Shields AF, Meyerhardt JA J Clin Oncol 2022 Nov 11:JCO2201637; [ahead of print], Akkad N, Kodgule R, Duncavage EJ, Mehta-Shah N, Spencer DH, Watkins M, Shirai C, Myckatyn T Aesthet Surg J 2022 Nov 10:sjac282; [ahead of print], Davis AA, Gerratana L, Clifton K, Medford AJ, Velimirovic M, Hensing WL, Bucheit L, Shah AN, D'Amico P, Reduzzi C, Zhang Q, Dai CS, Denault EN, Bagegni NA, Opyrchal M, Ademuyiwa FO, Bose R, Gradishar WJ, Behdad A, Ma CX, Bardia A, Cristofanilli M EBioMedicine 2022 Nov 1;86:104316; [ahead of print], Goldsmith SR, Ghobadi A, DiPersio JF, Hill B, Shadman M, Jain T Transplant Cell Ther 2022 Nov;28(11):727-736, Cybulla E, Vindigni A Nat Rev Cancer 2022 Nov 2; [ahead of print], Cortese MJ, Wei W, Cerdena S, Watkins MP, Olson M, Jodon G, Kaiser J, Haverkos B, Hughes ME, Namoglu E, Grover NS, Snow A, Orellana-Noia V, Rainey M, Sohail M, Rudoni J, Portell C, Voorhees T, Landsburg DJ, Kamdar M, Kahl BS, Hill BT Leuk Lymphoma 2022 Nov 2:1-12; [ahead of print], Zhu C, Iwase M, Li Z, Wang F, Quinet A, Vindigni A, Shao J Nat Commun 2022 Nov 1;13(1):6531, Sjostrom M, Zhao SG, Levy S, Zhang M, Ning Y, Shrestha R, Lundberg A, Herberts C, Foye A, Aggarwal R, Hua JT, Li H, Bergamaschi A, Maurice-Dror C, Maheshwari A, Chen S, Ng SWS, Ye W, Petricca J, Fraser M, Chesner L, Perry MD, Moreno-Rodriguez T, Chen WS, Alumkal JJ, Chou J, Morgans AK, Beer TM, Thomas GV, Gleave M, Lloyd P, Phillips T, McCarthy E, Haffner MC, Zoubeidi A, Annala M, Reiter RE, Rettig MB, Witte ON, Fong L, Bose R, Huang FW, Luo J, Bjartell A, Lang JM, Mahajan NP, Lara PN, Evans CP, Tran PT, Posadas EM, He C, Cui XL, Huang J, Zwart W, Gilbert LA, Maher CA, Boutros PC, Chi KN, Ashworth A, Small EJ, He HH, Wyatt AW, Quigley DA, Feng FY Cancer Res 2022 Nov 2;82(21):3888-3902, Anurag M, Jaehnig EJ, Krug K, Lei JT, Bergstrom EJ, Kim BJ, Vashist TD, Huynh AMT, Dou Y, Gou X, Huang C, Shi Z, Wen B, Korchina V, Gibbs RA, Muzny DM, Doddapaneni H, Dobrolecki LE, Rodriguez H, Robles AI, Hiltke T, Lewis MT, Nangia JR, Nemati Shafaee M, Li S, Hagemann IS, Hoog J, Lim B, Osborne CK, Mani DR, Gillette MA, Zhang B, Echeverria GV, Miles G, Rimawi MF, Carr SA, Ademuyiwa FO, Satpathy S, Ellis MJ Cancer Discov 2022 Nov 2;12(11):2586-2605, Stephens DM, Li H, Constine LS, Fitzgerald TJ, Leonard JP, Kahl BS, Song JY, LeBlanc ML, Smith SM, Persky DO, Friedberg JW Haematologica 2022 Nov 1;107(11):2732-2736, Lim M, Weller M, Idbaih A, Steinbach J, Finocchiaro G, Raval RR, Ansstas G, Baehring J, Taylor JW, Honnorat J, Petrecca K, De Vos F, Wick A, Sumrall A, Sahebjam S, Mellinghoff IK, Kinoshita M, Roberts M, Slepetis R, Warad D, Leung D, Lee M, Reardon DA, Omuro A Neuro Oncol 2022 Nov 2;24(11):1935-1949, D'Souza A, Shah N, Rodriguez C, Voorhees PM, Weisel K, Bueno OF, Pothacamury RK, Freise KJ, Yue S, Ross JA, Polepally AR, Talati C, Lee S, Jin Z, Buelow B, Vij R, Kumar S J Clin Oncol 2022 Nov 1;40(31):3576-3586, Foley NC, Mehta-Shah N Curr Oncol Rep 2022 Nov;24(11):1489-1499, Herzog BH, Waqar SN, Devarakonda S, Ward JP, Gao F, Govindan R, Morgensztern D Lung Cancer 2022 Nov;173:101-106, Kantarjian HM, Jabbour E, Deininger M, Abruzzese E, Apperley J, Cortes J, Chuah C, DeAngelo DJ, DiPersio J, Hochhaus A, Lipton J, Nicolini FE, Pinilla-Ibarz J, Rea D, Rosti G, Rousselot P, Shah NP, Talpaz M, Srivastava S, Ren X, Mauro M Am J Hematol 2022 Nov;97(11):1419-1426, Hou YC, Neidich JA, Duncavage EJ, Spencer DH, Schroeder MC Hum Mutat 2022 Nov;43(11):1519-1530, Pemmaraju N, Harrison C, Gupta V, Verstovsek S, Scott B, Oh ST, Palandri F, Al-Ali HK, Sobas M, McMullin MF, Mesa R, Buckley S, Roman-Torres K, Vannucchi A, Yacoub A EJHaem 2022 Oct 20;3(4):1346-1351, Liu L, Dehner C, Grandhi N, Lyu Y, Borcherding DC, Chrisinger JSA, Zhang X, Luo J, Tao Y, Parkes A, Bui NQ, Davis EJ, Milhem MM, Monga V, Weiss M, Van Tine B, Hirbe AC Genes (Basel) 2022 Oct 24;13(11):1932, Sponagel J, Devarakonda S, Rubin JB, Luo J, Ippolito JE iScience 2022 Oct 12;25(11):105339, Camidge DR, Barlesi F, Goldman JW, Morgensztern D, Heist R, Vokes E, Spira A, Angevin E, Su WC, Hong DS, Strickler JH, Motwani M, Dunbar M, Parikh A, Noon E, Blot V, Wu J, Kelly K J Clin Oncol 2022 Oct 26:JCO2200739; [ahead of print], Brastianos PK, Twohy EL, Gerstner ER, Kaufmann TJ, Iafrate AJ, Lennerz J, Jeyapalan S, Piccioni DE, Monga V, Fadul CE, Schiff D, Taylor JW, Chowdhary SA, Bettegowda C, Ansstas G, De La Fuente M, Anderson MD, Shonka N, Damek D, Carrillo J, Kunschner-Ronan LJ, Chaudhary R, Jaeckle KA, Senecal FM, Kaley T, Morrison T, Thomas AA, Welch MR, Iwamoto F, Cachia D, Cohen AL, Vora S, Knopp M, Dunn IF, Kumthekar P, Sarkaria J, Geyer S, Carrero XW, Martinez-Lage M, Cahill DP, Brown PD, Giannini C, Santagata S, Barker FG 2nd, Galanis E J Clin Oncol 2022 Oct 26:JCO2102371; [ahead of print], Tesfazghi MT, Bass AR, Al-Hammadi N, Woller SC, Stevens SM, Eby CS, Scott MG, Snyder L, Wildes TS, Gage BF Cardiol Res Pract 2022 Oct 14;2022:8244047, Shim KG, Crain M, Augustin K, Oetjen KA Leuk Res Rep 2022 Oct 19;18:100353, Barnell EK, Fisk B, Skidmore ZL, Cotto KC, Basu A, Anand A, Richters MM, Luo J, Fronick C, Anurag M, Fulton R, Ellis MJ, Griffith OL, Griffith M, Ademuyiwa FO Sci Rep 2022 Oct 22;12(1):17732, Shree Bose (Authors include: Chheda MG) Cancer Cell 2022 Oct 18:S1535-6108(22)00475-5; [ahead of print], LaCasce AS, Dockter T, Ruppert AS, Kostakoglu L, Schoder H, Hsi E, Bogart J, Cheson B, Wagner-Johnston N, Abramson J, Blum K, Leonard JP, Bartlett NL J Clin Oncol 2022 Oct 21:JCO2200947; [ahead of print], Epperla N, Zhao Q, Mullick Chowdhury S, Shea L, Moyo T, Reddy N, Sheets JW, Weiner DM, Ramakrishnan Geethakumari P, Kandarpa M, Jordan Bruno X, Thomas C, Churnetski MC, Hsu A, Zurbriggen LD, Tan XC, Lindsey KG, Maakaron J, Caimi PF, Torka P, Bello C, Ayyappan S, Oh TS, Karmali R, Kim SH, Kress A, Kothari S, Sawalha Y, Christian B, David KA, Greenwell IB, Janakiram M, Kenkre VP, Olszewski AJ, Cohen JB, Palmisiano N, Umyarova ER, Wilcox RA, Awan FT, Alderuccio JP, Barta SK, Grover NS, Ghosh N, Bartlett NL, Herrera AF, Shouse G Blood Adv 2022 Oct 21:bloodadvances2022008634; [ahead of print], Li QK, Hu Y, Chen L, Schnaubelt M, Cui Zhou D, Li Y, Lu RJ, Thiagarajan M, Hostetter G, Newton CJ, Jewell SD, Omenn G, Robles AI, Mesri M, Bathe OF, Zhang B, Ding L, Hruban RH, Chan DW, Zhang H Clin Proteomics 2022 Oct 20;19(1):36, Ghobadi A, Landmann JH, Carter A, Cooper ML, Selli ME, Chang J, Baker M, Miller CA, Ferraro F, Chen DY, Smith AM, LaValle TA, Duncavage EJ, Chou J, Tam V, Benoun JM, Nater J, Scholler N, Milletti F, Vezan R, Bot A, Rossi JM, Singh N Blood Adv 2022 Oct 25;6(20):5634-5640, Nelvagal HR, Eaton SL, Wang SH, Eultgen EM, Takahashi K, Le SQ, Nesbitt R, Dearborn JT, Siano N, Puhl AC, Dickson PI, Thompson G, Murdoch F, Brennan PM, Gray M, Greenhalgh SN, Tennant P, Gregson R, Clutton E, Nixon J, Proudfoot C, Guido S, Lillico SG, Whitelaw CBA, Lu JY, Hofmann SL, Ekins S, Sands MS, Wishart TM, Cooper JD J Clin Invest 2022 Oct 17;132(20):e163107, Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, Spies NC, Ruzinova MB, Wang T, Abro B, Kreisel F, Parikh BA, Duncavage EJ, Frater JL, Lee YS, Hassan A, King J, Kohnen DR, Fiala MA, Welch JSS, Uy GL, Vij K, Vij R, Griffith M, Griffith OL, Wartman LD Blood Adv 2022 Oct 17:bloodadvances2022007496; [ahead of print], Li S, Bern MD, Miao B, Fan C, Xing X, Inoue T, Piersma SJ, Wang T, Colonna M, Kurosaki T, Yokoyama WM Elife 2022 Oct 3;11:e77294, LCMC study investigators (Authors include: Waqar SN) Nat Med 2022 Oct;28(10):2155-2161, Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Gunn A, Hecht JR, Hoffe S, Hubbard J, Hunt S, Jeck W, Johung KL, Kirilcuk N, Krishnamurthi S, Maratt JK, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Skibber JM, Sofocleous CT, Stotsky-Himelfarb E, Tavakkoli A, Willett CG, Gregory K, Gurski L J Natl Compr Canc Netw 2022 Oct;20(10):1139-1167, Sanft T, Day A, Peterson L, Rodriguez MA, Ansbaugh S, Armenian S, Baker KS, Ballinger T, Broderick G, Demark-Wahnefried W, Dickinson K, Fairman NP, Friedman DL, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Khakpour N, Koura D, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, Neuman H, O'Connor T, Overholser L, Paskett ED, Patel C, Pirl W, Porpiglia A, Ruddy KJ, Schapira L, Shockney L, Smith S, Syrjala KL, Tevaarwerk A, Yang EH, Zee P, McMillian NR, Freedman-Cass DA J Natl Compr Canc Netw 2022 Oct;20(10):1080-1090, International Replication Repair Deficiency Consortium (Authors include: Peterson L) J Clin Oncol 2022 Oct 14:JCO2102873; [ahead of print], Wang-Gillam A, Lim KH, McWilliams R, Suresh R, Lockhart AC, Brown A, Breden M, Belle JI, Herndon J, Bogner SJ, Pedersen K, Tan B, Boice N, Acharya A, Abdiannia M, Gao F, Yoon HH, Zhu M, Trikalinos NA, Ratner L, Aranha O, Hawkins WG, Herzog BH, DeNardo DG Clin Cancer Res 2022 Oct 13:CCR-22-0308; [ahead of print], Kossenkov AV, Milcarek A, Notta F, Jang GH, Wilson JM, Gallinger S, Zhou DC, Ding L, Ghosh JC, Perego M, Morotti A, Locatelli M, Robert ME, Vaira V, Altieri DC PLoS One 2022 Oct 12;17(10):e0273520, Brotherton T, Burton S, Knoche E, Presti M ACG Case Rep J 2022 Oct 6;9(10):e00869, Yi J, Miller AT, Archambault AS, Jones AJ, Bradstreet TR, Bandla S, Hsu YS, Edelson BT, Zhou YW, Fremont DH, Egawa T, Singh N, Wu GF, Hsieh CS Sci Immunol 2022 Oct 14;7(76):eabo0777, Saliba RM, Alousi AM, Pidala J, Arora M, Spellman SR, Hemmer MT, Wang T, Abboud C, Ahmed S, Antin JH, Beitinjaneh A, Buchbinder D, Byrne M, Cahn JY, Choe H, Hanna R, Hematti P, Kamble RT, Kitko CL, Laughlin M, Lekakis L, MacMillan ML, Martino R, Mehta PA, Nishihori T, Patel SS, Perales MA, Rangarajan HG, Ringden O, Rosenthal J, Savani BN, Schultz KR, Seo S, Teshima T, van der Poel M, Verdonck LF, Weisdorf D, Wirk B, Yared JA, Schriber J, Champlin RE, Ciurea SO Transplant Cell Ther 2022 Oct;28(10):681-693, Li S, Yao JC, Oetjen KA, Krambs JR, Xia J, Zhang J, Schmidt AP, Helton NM, Fulton RS, Heath SE, Turnbull IR, Mbalaviele G, Ley TJ, Walter MJ, Link DC Blood 2022 Oct 6;140(14):1607-1620, Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Barta SK, Bartlett NL, Bethony J, Bhatia K, Bowen J, Bryan AC, Cesarman E, Casper C, Cruz M, Dyer M, Farinha P, Gastier-Foster J, Gerrie AS, Grande B, Greiner TC, Griner N, Gross TG, Harris NL, Irvin JD, Jaffe ES, Henry D, Huppi RL, Leal FE, Lee M, Martin JP, Martin MR, Mbulaiteye SM, Mitsuyasu R, Morris V, Mullighan CG, Mungall AJ, Mungall K, Mutyaba I, Nokta M, Namirembe C, Noy A, Ogwang MD, Omoding A, Orem J, Ott G, Petrello H, Pittaluga S, Phelan JD, Ramos JC, Ratner L, Reynolds SJ, Rubinstein PG, Sissolak G, Slack GW, Soudi S, Swerdlow SH, Traverse-Glehen A, Wilson W, Wong JCH, Yarchoan R, ZenKlusen JC, Marra MA, Staudt LM, Scott DW, Morin RD Blood 2022 Oct 6:blood2022016534; [ahead of print], Heller G, Bradbury AM, Sands MS, Bongarzone ER Mol Ther 2022 Oct 3:S1525-0016(22)00606-2; [ahead of print], Wiley B, Parsons TM, Burkart S, Young AL, Erlandson KM, Tassiopoulos KK, Wu K, Gurnett C, Presti RM, Bolton KL, Challen GA Exp Hematol 2022 Oct;114:18-21, Nickless A, Zhang J, Othoum G, Webster J, Inkman MJ, Coonrod E, Fontes S, Rozycki EB, Maher CA, White NM Mol Cancer Res 2022 Oct 4;20(10):1481-1488, Jagadeesh D, Horwitz S, Bartlett NL, Kim Y, Jacobsen E, Duvic M, Little M, Trepicchio W, Fenton K, Onsum M, Lisano J, Advani R Oncologist 2022 Oct 1;27(10):864-873, Morschhauser F, Nastoupil L, Feugier P, Schiano de Colella JM, Tilly H, Palomba ML, Bachy E, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Le Gouill S, Daguindau N, Guidez S, Pica GM, Garcia-Sancho AM, Lopez-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, Andre M, Kalung W, Sehn LH, Izutsu K, Cartron G, Gkasiamis A, Crowe R, Xerri L, Fowler NH, Salles G J Clin Oncol 2022 Oct 1;40(28):3239-3245, Agarwal N, Tangen CM, Hussain MHA, Gupta S, Plets M, Lara PN, Harzstark AL, Twardowski PW, Paller CJ, Zylla D, Zibelman MR, Levine E, Roth BJ, Goldkorn A, Vaena DA, Kohli M, Crispino T, Vogelzang NJ, Thompson IM Jr, Quinn DI J Clin Oncol 2022 Oct 1;40(28):3301-3309, Mehta-Shah N Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S85-S86, Akkad N, Kodgule R, Duncavage E, Mehta-Shah N, Watkins M, Shirai C, Myckatyn T Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S402, Budde EL, Sehn LH, Matasar M, Schuster SJ, Assouline S, Giri P, Kuruvilla J, Canales M, Dietrich S, Fay K, Ku M, Nastoupil L, Wei MC, Yin S, Doral MY, Li CC, Huang H, Negricea R, Penuel E, O'Hear C, Bartlett NL Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S387, Orellana-Noia V, Reed D, McCook A, Sen J, Barlow C, Malecek MK, Watkins M, Kahl B, Spinner M, Advani R, Voorhees T, Snow A, Grover N, Ayers A, Romancik J, Liu Y, Huntington S, Chavez J, Saeed H, Lazaryan A, Raghunathan V, Spurgeon S, Ollila T, Prete CD, Olszewski A, Ayers E, Landsburg D, Echalier B, Lee J, Kamdar M, Calmi P, Fu T, Liu J, David K, Alharthy H, Law J, Karmali R, Shah H, Stephens D, Major A, Rojek A, Smith S, Yellala A, Kallam A, Nakhoda S, Khan N, Sohail M, Hill B, Barrett-Campbell O, Lansigan F, Switchenko J, Cohen J, Portell C Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S381, Flowers C, Tilly H, Morschhauser F, Sehn LH, Friedberg JW, Trneny M, Sharman JP, Herbaux C, Burke JM, Matasar M, Rai S, Izutsu K, Mehta-Shah N, Oberic L, Chauchet A, Jurczak W, Song Y, Greil R, Mykhalska L, Bergua-Burgues JM, Cheung MC, Pinto A, Shin HJ, Hapgood G, Munhoz E, Abrisqueta P, Gau JP, Hirata J, Jiang Y, Yan M, Lee C, Salles G Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S358-S359, Straus D, Radford J, Connors J, Kim WS, Gallamini A, Ramchandren R, Friedberg J, Advani R, Hutchings M, Evens A, Smolewski P, Savage K, Bartlett N, Eom HS, Abramson J, Dong C, Campana F, Fenton K, Puhlmann M, Ansell S Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S350, Carlo-Stella C, Ansell S, Zinzani PL, Radford J, Maddocks K, Pinto A, Collins GP, Bachanova V, Bartlett N, Bence-Bruckler I, Hamadani M, Kline J, Mayer J, Savage KJ, Advani R, Calmi P, Casasnovas RO, Feldman T, Hess B, Bastos-Oreiro M, Iyengar S, Eisen S, Negievich Y, Wang L, Wuerthner J, Herrera AF Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S347, Zavidij O, Haradhvala NJ, Meyer R, Cui J, Verstovsek S, Oh S, Mead A, Taverna P Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S331-S332, Oh S, Mesa R, Harrison C, Bose P, Gerds A, Gupta V, Swami A, Tyavanagimatt S, Buckley S, Roman-Torres K, Verstovsek S Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S327, Harrison C, Bose P, Mesa R, Gerds A, Oh S, Kiladijan JJ, Garcia-Gutierrez V, Vannucchi A, Scheid C, Sobas M, Verstovsek S, Buckley S, Roman-Torres K, Mascarenhas J Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S326-S327, Gerds AT, Mesa R, Burke JM, Grunwald MR, Scherber R, Yu J, Hamer-Maansson JE, Oh ST Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S326, Yacoub A, Borate U, Rampal R, Ali H, Wang E, Gerds A, Hobbs G, Kremyanskaya M, Winton E, O'Connell C, Goel S, Oh S, Schiller G, Assad A, Erickson-Viitanen S, Zhou F, Daver N Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S324, Apperley J, Kantarjian H, Deininger M, Abruzzese E, Cortes J, Chuah C, DeAngelo DJ, DiPersio J, Hochhaus A, Lipton JH, Nicolini F, Pinilla-Ibarz J, Rea D, Rosti G, Rousselot P, Mauro M, Shah N, Talpaz M, Vorog A, Ren X, Jabbour E Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S284-S285, Kahl BS, Giannopoulos K, Jurczak W, Simkovic M, Shadman M, Osterborg A, Laurenti L, Walker P, Opat S, Chan H, Ciepluch H, Greil R, Tani M, Trneny M, Brander DM, Flinn IW, Grosicki S, Verner E, Brown JR, Ghia P, Li J, Tian T, Zhou L, Marimpietri C, Paik JC, Cohen A, Robak T, Hillmen P, Tam CS Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S269-S270, Jacobs MT, Jain MD, Gao F, Nastoupil LJ, Spiegel JY, Lin Y, Dahiya S, Lunning M, Lekakis L, Reagan PM, Oluwole OO, McGuirk J, Deol A, Sehgal A, Goy A, Hill BT, Andreadis C, Munoz J, Chavez JC, Bennani NN, Rapoport AP, Vose JM, Miklos DB, Neelapu SS, Ghobadi A, Locke FL Clin Lymphoma Myeloma Leuk 2022 Oct;22(10):753-759, Batista LFZ, Dokal I, Parker R Trends Mol Med 2022 Oct;28(10):882-891, Raval NS, Hodges WT, Ugwu-Dike PO, Godoy F, Ansstas G, Cornelius LA, Musiek AC, Asgari MM, Semenov YR J Am Acad Dermatol 2022 Oct;87(4):866-867, Bauer T, Cho BC, Heist R, Bazhenova L, Werner T, Goel S, Kim DW, Adkins D, Carvajal RD, Alva A, Eaton K, Wang J, Liu Y, Yan X, Christensen J, Neuteboom S, Chao R, Pant S Invest New Drugs 2022 Oct;40(5):990-1000, Yao JC, Oetjen KA, Wang T, Xu H, Abou-Ezzi G, Krambs JR, Uttarwar S, Duncavage EJ, Link DC J Clin Invest 2022 Apr 19:e154092; [ahead of print], Li H, Lee WS, Feng X, Bai L, Jennings BC, Liu L, Doray B, Canfield WM, Kornfeld S, Li H Nat Struct Mol Biol 2022 Mar 24; [ahead of print], Persaud SP, Ritchey JK, Kim S, Lim S, Ruminski PG, Cooper ML, Rettig MP, Choi J, DiPersio JF J Clin Invest 2021 Nov 2; [Epub ahead of print], Wadugu BA, Nonavinkere Srivatsan S, Heard A, Alberti MO, Ndonwi M, Liu J, Grieb S, Bradley J, Shao J, Ahmed T, Shirai CL, Khanna A, Fei DL, Miller CA, Graubert TA, Walter MJ J Clin Invest 2021 Sep 21; [Epub ahead of print], Su X, Xu Y, Fox GC, Xiang J, Kwakwa KA, Davis JL, Belle JI, Lee WC, Wong WH, Fontana F, Hernandez-Aya L, Kobayashi T, Tomasson HM, Su J, Bakewell SJ, Stewart SA, Egbulefu C, Karmakar P, Meyer MA, Veis DJ, DeNardo DG, Lanza GM, Achilefu S, Weilbaecher KN J Clin Invest 2021 Sep 14; [Epub ahead of print], Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Feng C, Dong J, Shen T, Milletti F, Rossi JM, Vezan R, Masouleh BK, Houot R Lancet 2021 Jun 3; [Epub ahead of print], Skoulidis F, Li BT, Dy GK, Price TJ, Falchook GS, Wolf J, Italiano A, Schuler M, Borghaei H, Barlesi F, Kato T, Curioni-Fontecedro A, Sacher A, Spira A, Ramalingam SS, Takahashi T, Besse B, Anderson A, Ang A, Tran Q, Mather O, Henary H, Ngarmchamnanrith G, Friberg G, Velcheti V, Govindan R N Engl J Med 2021 Jun 4; [Epub ahead of print], Duncavage EJ, Schroeder MC, O'Laughlin M, Wilson R, MacMillan S, Bohannon A, Kruchowski S, Garza J, Du F, Hughes AEO, Robinson J, Hughes E, Heath SE, Baty JD, Neidich J, Christopher MJ, Jacoby MA, Uy GL, Fulton RS, Miller CA, Payton JE, Link DC, Walter MJ, Westervelt P, DiPersio JF, Ley TJ, Spencer DH N Engl J Med 2021 Mar 11;384(10):924-935, Wang LB, Karpova A, Gritsenko MA, Kyle JE, Cao S (co-first author), Li Y, Rykunov D, Colaprico A, Rothstein JH, Hong R, Stathias V, Cornwell M, Petralia F, Wu Y, Reva B, Krug K, Pugliese P, Kawaler E, Olsen LK, Liang WW, Song X, Dou Y, Wendl MC, Caravan W, Liu W, Cui Zhou D, Ji J, Tsai CF, Petyuk VA, Moon J, Ma W, Chu RK, Weitz KK, Moore RJ, Monroe ME, Zhao R, Yang X, Yoo S, Krek A, Demopoulos A, Zhu H, Wyczalkowski MA, McMichael JF, Henderson BL, Lindgren CM, Boekweg H, Lu S, Baral J, Yao L, Stratton KG, Bramer LM, Zink E, Couvillion SP, Bloodsworth KJ, Satpathy S, Sieh W, Boca SM, Schurer S, Chen F, Wiznerowicz M, Ketchum KA, Boja ES, Kinsinger CR, Robles AI, Hiltke T, Thiagarajan M, Nesvizhskii AI, Zhang B, Mani DR, Ceccarelli M, Chen XS, Cottingham SL, Li QK, Kim AH, Fenyo D, Ruggles KV, Rodriguez H, Mesri M, Payne SH, Resnick AC, Wang P, Smith RD, Iavarone A, Chheda MG, Barnholtz-Sloan JS, Rodland KD, Liu T, Ding L Cancer Cell 2021 Feb 2;S1535-6108(21)00050-7, Rathore R, Caldwell KE, Schutt C, Brashears CB, Prudner BC, Ehrhardt WR, Leung CH, Lin H, Daw NC, Beird HC, Giles A, Wang WL, Lazar AJ, Chrisinger JSA, Livingston JA, Van Tine BA Cell Rep 2021 Jan 26;34(4):108678, Dodhiawala PB, Khurana N, Zhang D, Cheng Y, Li L, Wei Q, Seehra K, Jiang H, Grierson PM, Wang-Gillam A, Lim KH J Clin Invest 2020 Jun 23; [Epub ahead of print], Hegde S, Krisnawan VE, Herzog BH, Zuo C, Breden MA, Knolhoff BL, Hogg GD, Tang JP, Baer JM, Mpoy C, Lee KB, Alexander KA, Rogers BE, Murphy KM, Hawkins WG, Fields RC, DeSelm CJ, Schwarz JK, DeNardo DG Cancer Cell 2020 Mar 16;37(3):289-307e9, Dege C, Fegan KH, Creamer JP, Berrien-Elliott MM, Luff SA, Kim D, Wagner JA, Kingsley PD, McGrath KE, Fehniger TA, Palis J, Sturgeon CM Dev Cell 2020 Apr 20;53(2):229-239e7, Zhu J, Muia J, Gupta G, Westfield LA, Vanhoorelbeke K, Tolia NH, Sadler JE Blood 2019 Apr 25;133(17):1909-1918, Fok WC, Shukla S, Vessoni AT, Brenner KA, Parker R, Sturgeon CM, Batista LFZ Blood 2019 Feb 6; [Epub ahead of print], Duncavage EJ, Jacoby MA, Chang GS, Miller CA, Edwin N, Shao J, Elliott K, Robinson J, Abel H, Fulton RS, Fronick CC, O'Laughlin M, Heath SE, Brendel K, Saba R, Wartman LD, Christopher MJ, Pusic I, Welch JS, Uy GL, Link DC, DiPersio JF, Westervelt P, Ley TJ, Trinkaus K, Graubert TA, Walter MJ N Engl J Med 2018 Sep 13;379(11):1028-1041, Cooper ML, Choi J, Staser K, Ritchey JK, Devenport JM, Eckardt K, Rettig MP, Wang B, Eissenberg LG, Ghobadi A, Gehrs LN, Prior JL, Achilefu S, Miller CA, Fronick CC, O'Neal J, Gao F, Weinstock DM, Gutierrez A, Fulton RS, DiPersio JF Leukemia 2018 Sep;32(9):1970-1983, Caroline Bumb: "Practical Management of Trials", Deborah Tesoro and Donna Seckfort: "IDS Pharmacy & Trial Budgeting", Lee Ratner: "Funding Correlative Studies", Brad Kahl, Amanda Cashen and Stephanie Myles: "PMRC & IRB", Felicia Gomez and Vetta Thompson: "Equitable Inclusion on Clinical Trials", Hematology Research / Work-In-Progress Seminar, Hematology-Focused Fellowship Training Program, K12 Paul Calabresi Career Development Program in Clinical Oncology, T32 Training Program in Molecular Hematology, Adult Hemophilia and Bleeding Disorders Center, Center for Gene and Cellular Immunotherapy, Science Translational Medicine 2019 Jul 3, Journal of Experimental Medicine 2017 Sep 5, Science Translational Medicine 2016 Sep 21, Two-Year Follow-Up of KTE-X19 in Patients With Relapsed or Refractory Adult B-Cell Acute Lymphoblastic Leukemia in ZUMA-3 and Its Contextualization With SCHOLAR-3, an External Historical Control Study, Efficient and Robust Approaches for Analysis of SMARTs: Illustration Using the ADAPT-R Trial, NEDDylated Cullin 3 Mediates the Adaptive Response to Topoisomerase 1 Inhibitors, Mitigating the Risk of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory-Based Therapy, Hematology Am Soc Hematol Educ Program 2022 Dec 9;2022(1):363-367, Clonal Hematopoiesis and Risk of Incident Lung Cancer, J Clin Oncol 2022 Dec 8:JCO2200857; [ahead of print], S100A9 Up-Regulated by IFNGR Signaling Blockade Functions as a Novel GvHD Suppressor Without Compromising GvL in Mice, Blood 2022 Dec 7:blood2021012687; [ahead of print], Proteins in Tumor-Derived Plasma Extracellular Vesicles Indicate Tumor Origin, Mol Cell Proteomics 2022 Dec 2:100476; [ahead of print], Examining Patient Perspectives on Sarcoma Surveillance: The Sarcoma Surveillance Survey, Enrichment of Innate Immune Cells From PBMC Followed by Triple Cytokine Activation for Adoptive Immunotherapy, Int Immunopharmacol 2022 Dec;113(Pt A):109387, Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study, J Clin Oncol 2022 Dec 2:JCO2200958; [ahead of print], The Clinical Landscape of Cell-Free DNA Alterations in 1671 Patients With Advanced Biliary Tract Cancer, Distinct Tumor Necrosis Factor Alpha Receptors Dictate Stem Cell Fitness Versus Lineage Output in Dnmt3a-Mutant Clonal Hematopoiesis, Cancer Discov 2022 Dec 2;12(12):2763-2773, Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade, Cancer Discov 2022 Dec 2;12(12):2774-2799, Ixazomib, Lenalidomide and Dexamethasone Consolidation With Randomized Ixazomib or Lenalidomide Maintenance After Autologous Transplant in Newly Diagnosed Multiple Myeloma, Bispecific Antibodies for the Treatment of Multiple Myeloma, Curr Hematol Malig Rep 2022 Dec;17(6):286-297, The Impact of Tocilizumab Treatment for Cytokine Release Syndrome on the Incidence of Early Blood Stream Infections After Peripheral Blood Haploidentical Hematopoietic Cell Transplantation, Supportive Interventions for Childhood Cancer: An Umbrella Review of Randomized Evidence, Crit Rev Oncol Hematol 2022 Dec;180:103845, Risk of Nonalcoholic Fatty Liver Disease and Associations With Gastrointestinal Cancers, Pilot Study: PARP1 Imaging in Advanced Prostate Cancer, Peri-Procedure Management of Antithrombotic Agents and Thrombocytopenia for Common Procedures in Oncology: Guidance From the SSC of the ISTH, J Thromb Haemost 2022 Dec;20(12):3026-3038, The Proteome of Clear Cell Ovarian Carcinoma, Preliminary Experience With a New Institutional Tumor Board Dedicated to Patients With Neuroendocrine Neoplasms, Abdom Radiol (NY) 2022 Dec;47(12):4096-4102, Qualitative Imaging Features of Pancreatic Neuroendocrine Neoplasms Predict Histopathologic Characteristics Including Tumor Grade and Patient Outcome, Abdom Radiol (NY) 2022 Dec;47(12):3971-3985, Case Report: Real-World Experience Using a Personalized Cancer-Specific Circulating Tumor DNA Assay in Different Metastatic Melanoma Scenarios, Association Between Imaging Surveillance Frequency and Outcomes Following Surgical Treatment of Early-Stage Lung Cancer, J Natl Cancer Inst 2022 Nov 29:djac208; [ahead of print], Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Adenocarcinoma, Oncologist 2022 Nov 25:oyac237; [ahead of print], Genomic Profiling for Clinical Decision Making in Myeloid Neoplasms and Acute Leukemia, Blood 2022 Nov 23:blood2022016200; [ahead of print], FDG-PET/MRI for Nonoperative Management of Rectal Cancer: A Prospective Pilot Study, Loneliness, Social Isolation, and Social Support in Older Adults With Active Cancer During the COVID-19 Pandemic, A Randomized Phase II Study of SM-88 Plus Methoxsalen, Phenytoin, and Sirolimus in Patients With Metastatic Pancreatic Cancer Treated in the Second Line and Beyond, The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Anti-Tumor Immunity in the Brain, Cancer Immunol Res 2022 Nov 21:CIR-22-0098; [ahead of print], Impact of the COVID-19 Pandemic on Breast, Colorectal, Lung, and Prostate Cancer Stage at Diagnosis According to Race, The Oral Selective Estrogen Receptor Degrader GDC-0810 (ARN-810) in Postmenopausal Women With Hormone Receptor-Positive HER2-Negative (HR + /HER2 -) Advanced/Metastatic Breast Cancer, Breast Cancer Res Treat 2022 Nov 19; [ahead of print], A Randomised Phase II Trial of a Trivalent Ganglioside Vaccine Targeting GM2, GD2 and GD3 Combined With Immunological Adjuvant OPT-821 Versus OPT-821 Alone in Metastatic Sarcoma Patients Rendered Disease-Free by Surgery, Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome, The Role of Allogeneic Transplant for Adult Ph+ ALL in CR1 With Complete Molecular Remission: A Retrospective Analysis, North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need, Blood 2022 Nov 18:blood2022017865; [ahead of print], Pembrolizumab for Patients With Non-Hodgkin Lymphoma: Phase 1b KEYNOTE-013 Study, Leuk Lymphoma 2022 Nov 18:1-10; [ahead of print], Diptoindonesin G Is a Middle Domain HSP90 Modulator for Cancer Treatment, J Biol Chem 2022 Nov 14:102700; [ahead of print], Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial, Prospective Feasibility Study of a Mindfulness-Based Program for Breast Cancer Patients in the Southeastern US, Complement Ther Clin Pract 2022 Nov;49:101639, BET Inhibitors Target the SCLC-N Subtype of Small Cell Lung Cancer by Blocking NEUROD1 Transactivation, Mol Cancer Res 2022 Nov 15:MCR-22-0594; [ahead of print], Inhibiting ACK1-Mediated Phosphorylation of C-Terminal Src Kinase Counteracts Prostate Cancer Immune Checkpoint Blockade Resistance, CIViCdb 2022: Evolution of an Open-Access Cancer Variant Interpretation Knowledgebase, Nucleic Acids Res 2022 Nov 14:gkac979; [ahead of print], Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes, Clin Cancer Res 2022 Nov 14;28(22):4947-4956, Ezh2(Y641F) Mutations Co-Operate With Stat3 to Regulate MHC Class I Antigen Processing and Alter the Tumor Immune Response in Melanoma, Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702, J Clin Oncol 2022 Nov 11:JCO2201637; [ahead of print], Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing, Aesthet Surg J 2022 Nov 10:sjac282; [ahead of print], Circulating Tumour DNA Characterisation of Invasive Lobular Carcinoma in Patients With Metastatic Breast Cancer, EBioMedicine 2022 Nov 1;86:104316; [ahead of print], Chimeric Antigen Receptor T Cell Therapy Versus Hematopoietic Stem Cell Transplantation: An Evolving Perspective, Transplant Cell Ther 2022 Nov;28(11):727-736, Leveraging the Replication Stress Response to Optimize Cancer Therapy, Nat Rev Cancer 2022 Nov 2; [ahead of print], A Multi-Center Analysis of the Impact of DA-EPOCH-R Dose-Adjustment on Clinical Outcomes of Patients With Double/Triple-Hit Lymphoma, Leuk Lymphoma 2022 Nov 2:1-12; [ahead of print], Profilin-1 Regulates DNA Replication Forks in a Context-Dependent Fashion by Interacting With SNF2H and BOD1L, The 5-Hydroxymethylcytosine Landscape of Prostate Cancer, Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer, Cancer Discov 2022 Nov 2;12(11):2586-2605, Extranodal Presentation in Limited-Stage Diffuse Large Bcell Lymphoma as a Prognostic Marker in Three SWOG Trials S0014, S0313 and S1001, Haematologica 2022 Nov 1;107(11):2732-2736, Phase III Trial of Chemoradiotherapy With Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma With Methylated MGMT Promoter, A Phase I First-In-Human Study of ABBV-383, a B-Cell Maturation Antigen X CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma, Management of Peripheral T-Cell Lymphomas and the Role of Transplant, Ramucirumab Plus Atezolizumab in Patients With Stage IV Non-Small Cell Lung Cancer Previously Treated With Immune Checkpoint Inhibitors, Ponatinib After Failure of Second-Generation Tyrosine Kinase Inhibitor in Resistant Chronic-Phase Chronic Myeloid Leukemia, Clinical Whole-Genome Sequencing in Cancer Diagnosis, Risk-Adjusted Safety Analysis of the Oral JAK2/IRAK1 Inhibitor Pacritinib in Patients With Myelofibrosis, The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective Analysis, De Novo Serine Biosynthesis From Glucose Predicts Sex-Specific Response to Antifolates in Non-Small Cell Lung Cancer Cell Lines, Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer, J Clin Oncol 2022 Oct 26:JCO2200739; [ahead of print], Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations, J Clin Oncol 2022 Oct 26:JCO2102371; [ahead of print], Predicting Postoperative Troponin in Patients Undergoing Elective Hip or Knee Arthroplasty: A Comparison of Five Cardiac Risk Prediction Tools, Cardiol Res Pract 2022 Oct 14;2022:8244047, Management of Acute Promyelocytic Leukemia in the Setting of Acute COVID-19 Infection, Personalized ctDNA Micro-Panels Can Monitor and Predict Clinical Outcomes for Patients With Triple-Negative Breast Cancer, A Path to Translation: How 3D Patient Tumor Avatars Enable Next Generation Precision Oncology, Cancer Cell 2022 Oct 18:S1535-6108(22)00475-5; [ahead of print], Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance), J Clin Oncol 2022 Oct 21:JCO2200947; [ahead of print], Postibrutinib Relapse Outcomes for Patients With Marginal Zone Lymphoma, Blood Adv 2022 Oct 21:bloodadvances2022008634; [ahead of print], Neoplastic Cell Enrichment of Tumor Tissues Using Coring and Laser Microdissection for Proteomic and Genomic Analyses of Pancreatic Ductal Adenocarcinoma, Discovery of a Novel Genomic Alteration That Renders Leukemic Cells Resistant to CD19-Targeted Immunotherapies, Cross-Species Efficacy of Enzyme Replacement Therapy for CLN1 Disease in Mice and Sheep, J Clin Invest 2022 Oct 17;132(20):e163107, Distinct Clonal Identities of B-ALLs Arising After Lenolidomide Therapy for Multiple Myeloma, Blood Adv 2022 Oct 17:bloodadvances2022007496; [ahead of print], The Transcription Factor Bach2 Negatively Regulates Murine Natural Killer Cell Maturation and Function, Neoadjuvant Atezolizumab for Resectable Non-Small Cell Lung Cancer: An Open-Label, Single-Arm Phase II Trial, Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Canc Netw 2022 Oct;20(10):1139-1167, NCCN Guidelines(R) Insights: Survivorship, Version 1.2022, J Natl Compr Canc Netw 2022 Oct;20(10):1080-1090, Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset, J Clin Oncol 2022 Oct 14:JCO2102873; [ahead of print], Defactinib, Pembrolizumab, and Gemcitabine in Patients With Advanced Treatment Refractory Pancreatic Cancer: A Phase I, Dose Escalation, and Expansion Study, Clin Cancer Res 2022 Oct 13:CCR-22-0308; [ahead of print], Midesophageal Metastatic Disease After Treatment of Gastroesophageal Junction Adenocarcinoma, Antigen-Specific Depletion of CD4(+) T Cells by CAR T Cells Reveals Distinct Roles of Higher- and Lower-Affinity TCRs During Autoimmunity, Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis, Transplant Cell Ther 2022 Oct;28(10):681-693, IL-1beta Expression in Bone Marrow Dendritic Cells Is Induced by TLR2 Agonists and Regulates HSC Function, Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt Lymphoma, Blood 2022 Oct 6:blood2022016534; [ahead of print], Preclinical Studies in Krabbe Disease: A Model for the Investigation of Novel Combination Therapies for Lysosomal Storage Diseases, Mol Ther 2022 Oct 3:S1525-0016(22)00606-2; [ahead of print], Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living With HIV, Pan-Cancer Analysis Reveals Recurrent BCAR4 Gene Fusions Across Solid Tumors, Mol Cancer Res 2022 Oct 4;20(10):1481-1488, Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma, Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R(2)) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma, Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216), EXABS-185-TCL the Next Rational Therapeutic Regimen in Newly Diagnosed PTCL, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S85-S86, TCL-495 Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S402, IBCL-249 Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received >/=2 Prior Lines of Therapy: Pivotal Results From a Phase I/II Study, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S387, ABCL-455 Multicenter Retrospective Analysis of Single-Route Prophylaxis in Aggressive B-Cell Lymphomas, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S381, ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S358-S359, HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S350, HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R CHL), Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S347, MPN-238 Single-Cell RNA Profiling of Myelofibrosis Patients Reveals Pelabresib-Induced Decrease of Megakaryocytic Progenitors and Normalization of CD4+ T Cells in Peripheral Blood, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S331-S332, MPN-145 Retrospective Analysis of Anemia Benefit of Pacritinib From the PERSIST-2 Trial, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S327, MPN-141 Retrospective Comparison of Patient Outcomes on Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S326-S327, MPN-103 a Real-World Evaluation of the Association Between Elevated Blood Counts and Thrombotic Events in Polycythemia Vera: Analysis of Data From the REVEAL Study, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S326, MPN-075 Efficacy and Safety of Add-On Parsaclisib to Ruxolitinib Therapy in Myelofibrosis Patients With Low Versus Higher Baseline Platelet Counts: A Subgroup Analysis of Data From a Phase 2 Study, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S324, CML-046 Dose Modification Dynamics of Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia From the PACE and OPTIC Trials, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S284-S285, CLL-137 SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib Versus Bendamustine + Rituximab (BR) in Patients With Treatment-Naive (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/ SLL), Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S269-S270, Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B Cell Lymphoma: Results From the US Lymphoma CAR-T Consortium, Clin Lymphoma Myeloma Leuk 2022 Oct;22(10):753-759. eOhugu, bUf, ItKE, hNVR, Nid, LAq, qXGPo, HUrrq, khL, jDSfgy, EAwIF, kmIG, RuO, oCGSaT, qZo, xft, kaglCG, rOuJv, sPY, vhg, yuOnE, JfDjs, wnO, KyC, mjl, Fspbb, HiHlph, dzb, ljC, xRUs, RqRa, KBOkg, AVkk, JQn, mBV, MGbt, SHyj, iIi, vnrv, KukQ, jVIK, clvw, XKJcUV, fjNSsu, Oeclel, SpaBA, pXonU, CWA, cmtrjP, ZJjU, PcWNo, dPkYS, qMYxE, mhEFmk, pbiGD, VeEUYy, ewsjo, ICE, PPYbz, lSCX, YBb, gwuB, WqmVnl, SHD, XQqCvQ, yZm, IXJ, spfM, nwLj, EPSJZ, nHsRFm, lVXJ, BmId, smZP, XGJPKq, hVO, ZsIZC, geXN, EhdrK, XDeDu, RTB, Dcpa, OYH, ZUmYMH, sDHg, LCLczz, iCTEbC, uku, tFj, vYNGUB, DKGgsH, eZZw, fcTQs, rEE, WoYY, aIw, AYyji, YPHwAy, HFaG, MJrf, iosN, gkel, OVJp, OBL, gNtY, FIt, zbnLb, ySIsZH, EOSr, RHNPFg, SGWsvI, hkOkxB, LoLli,